Research background · Updated November 1, 2026
Pancragen Research: Publications, Study Types and Background
Short answer
Pancragen. As of November 1, 2026, PubMed indexes 7 records matching Pancragen, the earliest from 2006; 0 were published in 2021–2025 and 0 are reviews. ClinicalTrials.gov lists 0 registered studies matching the compound.
- PubMed records
- 7
- Earliest record
- 2006
- Published 2021–2025
- 0
- Reviews
- 0
- Animal-only studies
- 4
- Registered studies
- 0
Publications per year, 2006–2025
0 records in 2016–2025 against 7 in 2006–2015; the busiest year was 2006, with 1.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 0 |
| 2017 | 0 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 0 |
| 2023 | 0 |
| 2024 | 0 |
| 2025 | 0 |
Study types
| All PubMed records | 7 |
|---|---|
| Reviews | 00% |
| Animal studies (no human subjects indexed) | 457% |
| Indexed as clinical trials | 00% |
| Registered on ClinicalTrials.gov | 0 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 2 of the most-cited and most recent Pancragen papers report, in their own authors’ terms. Each line links the paper it came from.
Glucose and insulin in old primates
In old monkeys, pancragen and glimepiride both lowered basal blood glucose, and pancragen also normalized insulin and C-peptide levels.
AnimalsGoncharova ND 2015Advances in gerontologyPMID 28509500
Capillary endothelium in early diabetes
In an early-diabetes animal model, pancragen normalized adhesion of mesenteric capillary endothelium without changing capillary permeability, which the authors describe as an endothelioprotective effect.
AnimalsKhavinson VKh 2007Bulletin of experimental biology and medicinePMID 18642713
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 7 of the 7 records. They describe what the literature is about, not what Pancragen does.
- Cell Differentiation2 papers
- Pancreas2 papers
- Aging2 papers
- Glucose Intolerance1 papers
- Sulfonylurea Compounds1 papers
- Diabetes Mellitus, Type 21 papers
- Blood Glucose1 papers
- Capillary Permeability1 papers
Key papers
Earliest indexed record
Zakutskiĭ AN (2006). Advances in gerontology = Uspekhi gerontologii.
PMID 17152728
Citation counts from NIH iCite, among the 7 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| Identity data | On request |
|---|
Identity data from PubChem, retrieved November 1, 2026, on the Pancragen page.
How these numbers were counted
- PubMed search, run November 1, 2026:
pancragen[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
pancragenre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Pancragen outside a laboratory.
Wholesale supply
Pancragen, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Pancragen research questions
How much research has been published on Pancragen?
PubMed indexes 7 records matching Pancragen (searched November 1, 2026), including 0 reviews and 0 records indexed as clinical trials. 0 were published in the five years 2021–2025.
When was Pancragen first described in the literature?
The earliest PubMed record matching Pancragen is from 2006 (Zakutskiĭ AN, Advances in gerontology = Uspekhi gerontologii, PMID 17152728).
What topics does the Pancragen literature cover?
The subject headings PubMed indexers most often marked as a main topic of Pancragen papers are Cell Differentiation, Pancreas, Aging, Glucose Intolerance. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Pancragen sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Pancragen wholesale for research?
We source Pancragen to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.